ALLMedicine™ Pediatric HIV Infection Center
Research & Reviews 129 results
https://doi.org/10.1038/s41390-021-01393-x 10.1038/82139 10.1016/S2213-2600(15)00063-6 10.1016/j.tube.2015.04.003 10.1001/archinte.163.9.1009 10.4084/mjhid.2013.064 10.1179/027249302125000832 10.1016/S1473-3099(08)70182-8 10.1186/s41479-016-0023-9 10.1097/COH.0000000000000500 10.1086/595012 10.1097/INF.0000000000001062 10.1056/NEJMoa991159 10.1016/S2352-3018(18)30059-6 10.1111/cei.12251 10.3389/fimmu.2016.00190 10.1056/NEJMoa1511691 10.1093/infdis/jix291 10.1097/QAD.0000000000001673 10.1093/ije/dyx136 10.1097/QAD.0000000000001211 10.1590/s1678-9946201759030 10.1182/blood.V96.12.3866.h8003866_3866_3871 10.3389/fimmu.2017.02002 10.1097/COH.0000000000000231 10.1016/j.humimm.2013.06.010 10.3389/fimmu.2016.00310 10.1097/QAD.0000000000000292 10.1186/1471-2334-14-236 10.4049/jimmunol.1801024 10.1097/QAD.0000000000002128 10.1126/scitranslmed.aac5547 10.1093/tropej/fmq024 10.1016/S1473-3099(16)00055-4 10.1038/srep06690 10.1097/COH.0000000000000239 10.1128/CVI.00356-14 10.1086/315458 10.1002/cpt.1221 10.1002/path.1711690209 10.1165/rcmb.2010-0152RT 10.4049/jimmunol.1801135 10.1002/ppul.10343 10.1097/00063198-200305000-00010 10.1002/ppul.20676 10.1007/s00247-009-1156-2 10.1002/ppul.22840 10.1155/2011/354208 10.1186/s41479-016-0021-y 10.1016/S0140-6736(06)68507-3 10.1016/j.vaccine.2006.07.020 10.1016/j.vaccine.2007.06.045 10.1128/CVI.00360-16 10.1179/146532805X45665 10.1097/00002030-199903110-00009 10.1097/00002030-199709000-00011 10.1097/00006454-200211000-00016 10.5588/ijtld.10.0501 10.1056/NEJMoa1011214 10.1146/annurev.immunol.22.012703.104635 10.1111/cmi.12092 10.3389/fcimb.2014.00031 10.1016/j.tube.2006.12.006 10.1172/JCI128877 10.1182/blood-2006-04-015172 10.1182/blood-2010-03-273482 10.1084/jem.193.3.271 10.1164/rccm.2204027 10.1007/s00281-015-0490-8 10.1073/pnas.1811380116 10.4049/jimmunol.1101122 10.1183/09031936.00114810 10.1016/S1473-3099(15)00135-8 10.1038/mi.2012.39 10.1038/mi.2012.38 10.1189/jlb.2A0114-016R 10.1189/jlb.4A0514-266RR 10.4049/jimmunol.179.10.6973 10.1189/jlb.0908574 10.1084/jem.20100090 10.4049/jimmunol.1700558 10.1002/eji.201545545 10.1371/journal.pone.0118654 10.1093/infdis/jiu505 10.1128/IAI.00083-16 10.4049/jimmunol.178.11.7222 10.1016/j.cell.2016.08.072 10.1002/path.1628 10.1111/j.1462-5822.2005.00612.x 10.1016/j.ajpath.2012.05.009 10.1128/JVI.02471-15 10.1038/nm.3109 10.1016/j.it.2014.08.007 10.1172/JCI97508 10.1016/j.smim.2014.09.006 10.1016/j.cmi.2019.02.015 10.1165/rcmb.2015-0146OC 10.1165/rcmb.2015-0147LE 10.1016/j.immuni.2013.04.004 10.1016/j.immuni.2012.12.001 10.1016/j.chom.2018.08.001 10.3389/fimmu.2019.01435 10.1038/mi.2013.127 10.1007/s00441-010-1032-2 10.1242/dev.129122 10.3389/fimmu.2020.00486 10.1128/IAI.05707-11 10.1093/infdis/jix625 10.1371/journal.ppat.1004603 10.1016/j.smim.2014.09.009 10.3389/fimmu.2019.00417 10.1007/s00281-015-0534-0 10.1007/s00702-011-0681-y 10.3324/haematol.2010.025924 10.3389/fimmu.2014.00384 10.1128/JVI.00994-16 10.1111/febs.13966 10.1084/jem.20071367 10.1128/IAI.70.8.4501-4509.2002 10.1016/S1473-3099(13)70253-6 10.4049/jimmunol.1800235 10.1007/s00247-017-3867-0 10.1136/adc.83.4.342 10.1172/JCI83379 10.3389/fimmu.2017.01120 10.1007/s00408-012-9440-6 10.1086/651492 10.5588/ijtld.10.0483 10.1016/S1473-3099(10)70078-5 10.1086/644784 10.1164/rccm.200806-858OC 10.2217/fmb.15.9 10.1097/INF.0000000000000331 10.1097/COH.0000000000000241 10.1097/QAI.0b013e31829f6df2 10.1097/01.aids.0000202648.18526.bf 10.1183/09031936.00091010 10.1038/ncomms9451 10.1002/ppul.23221 10.1097/INF.0000000000001784 10.3389/fped.2019.00159
Pediatric Research; Xu H, Blair RV et. al.
Mar 18th, 2021 - Tuberculosis (TB) is an increasing global emergency in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patients, in which host immunity is dysregulated and compromised. However, the pathogenesis and efficacy of therapeu...
https://emedicine.medscape.com/article/965086-overview
Mar 4th, 2020 - Practice Essentials Since the first cases of human immunodeficiency virus (HIV) infection were identified, the number of children infected with HIV has risen dramatically in developing countries, the result of an increased number of HIV-infected w...
https://doi.org/10.1111/pai.13155
Pediatric Allergy and Immunology : Official Publication O... Parigi S, Licari A et. al.
Feb 5th, 2020 - Nowadays, it is spreading the false perception that pediatric HIV infection has been almost completely disappeared in Italy, as well as in other Western countries, and it does not deserve the attention of the primary care pediatrician anymore. Her...
https://emedicine.medscape.com/article/2058830-print
Dec 4th, 2019 - The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, developed by the HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, were updated in September 2019.[1] Significant changes to guideli...
https://emedicine.medscape.com/article/2058830-overview
Dec 4th, 2019 - CDC Guidelines The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, developed by the HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, were updated in September 2019. [1] Significant ch...
Guidelines 5 results
https://aidsinfo.nih.gov/guidelines/html/5/pediatric-opportunistic-infection/0
Office of AIDS Research Advisory Council
Jan 8th, 2019 - This report updates the last version of the Guidelines for the Prevention and Treatment of Opportunistic Infections (OIs) in HIV-Exposed and HIV-Infected Children, published in 2013. 1 These guidelines are intended for use by clinicians and other h.
https://aidsinfo.nih.gov/guidelines/html/2/pediatric-arv/0
Office of AIDS Research Advisory Council
Dec 13th, 2018 - The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (Pediatric Guidelines) address the use of antiretroviral therapy (ART) for children living with HIV, including adolescents with sexual maturity rating (SMR, formerly Ta.
https://aidsinfo.nih.gov/guidelines/html/3/perinatal/0
Office of AIDS Research Advisory Council
Dec 6th, 2018 - Recommendations regarding HIV screening in pregnancy, treatment of pregnant women who are living with HIV, and the use of antiretroviral (ARV) drugs for prevention of perinatal transmission of HIV have evolved considerably in the United States sin.
https://aidsinfo.nih.gov/guidelines/html/6/caring-for-persons-with-hiv-in-disaster-areas/0
Office of AIDS Research Advisory Council
Sep 13th, 2018 - The following information provides guidance to health care providers attending to the medical needs of adults and children with HIV who have been displaced from disaster areas and who have not yet secured HIV care in the areas where they have relo.
http://www.who.int/nutrition/publications/hivaids/hiv-if-emergencies-guidance/en/
WHO
May 31st, 2018 - The purpose of this document is to provide operational guidance on HIV and infant feeding in emergencies. It is intended to be used to complement emergency and sectoral guidelines on health, nutrition and HIV, including specifically infant feeding.
Clinicaltrials.gov 141 results
https://doi.org/10.1038/s41390-021-01393-x 10.1038/82139 10.1016/S2213-2600(15)00063-6 10.1016/j.tube.2015.04.003 10.1001/archinte.163.9.1009 10.4084/mjhid.2013.064 10.1179/027249302125000832 10.1016/S1473-3099(08)70182-8 10.1186/s41479-016-0023-9 10.1097/COH.0000000000000500 10.1086/595012 10.1097/INF.0000000000001062 10.1056/NEJMoa991159 10.1016/S2352-3018(18)30059-6 10.1111/cei.12251 10.3389/fimmu.2016.00190 10.1056/NEJMoa1511691 10.1093/infdis/jix291 10.1097/QAD.0000000000001673 10.1093/ije/dyx136 10.1097/QAD.0000000000001211 10.1590/s1678-9946201759030 10.1182/blood.V96.12.3866.h8003866_3866_3871 10.3389/fimmu.2017.02002 10.1097/COH.0000000000000231 10.1016/j.humimm.2013.06.010 10.3389/fimmu.2016.00310 10.1097/QAD.0000000000000292 10.1186/1471-2334-14-236 10.4049/jimmunol.1801024 10.1097/QAD.0000000000002128 10.1126/scitranslmed.aac5547 10.1093/tropej/fmq024 10.1016/S1473-3099(16)00055-4 10.1038/srep06690 10.1097/COH.0000000000000239 10.1128/CVI.00356-14 10.1086/315458 10.1002/cpt.1221 10.1002/path.1711690209 10.1165/rcmb.2010-0152RT 10.4049/jimmunol.1801135 10.1002/ppul.10343 10.1097/00063198-200305000-00010 10.1002/ppul.20676 10.1007/s00247-009-1156-2 10.1002/ppul.22840 10.1155/2011/354208 10.1186/s41479-016-0021-y 10.1016/S0140-6736(06)68507-3 10.1016/j.vaccine.2006.07.020 10.1016/j.vaccine.2007.06.045 10.1128/CVI.00360-16 10.1179/146532805X45665 10.1097/00002030-199903110-00009 10.1097/00002030-199709000-00011 10.1097/00006454-200211000-00016 10.5588/ijtld.10.0501 10.1056/NEJMoa1011214 10.1146/annurev.immunol.22.012703.104635 10.1111/cmi.12092 10.3389/fcimb.2014.00031 10.1016/j.tube.2006.12.006 10.1172/JCI128877 10.1182/blood-2006-04-015172 10.1182/blood-2010-03-273482 10.1084/jem.193.3.271 10.1164/rccm.2204027 10.1007/s00281-015-0490-8 10.1073/pnas.1811380116 10.4049/jimmunol.1101122 10.1183/09031936.00114810 10.1016/S1473-3099(15)00135-8 10.1038/mi.2012.39 10.1038/mi.2012.38 10.1189/jlb.2A0114-016R 10.1189/jlb.4A0514-266RR 10.4049/jimmunol.179.10.6973 10.1189/jlb.0908574 10.1084/jem.20100090 10.4049/jimmunol.1700558 10.1002/eji.201545545 10.1371/journal.pone.0118654 10.1093/infdis/jiu505 10.1128/IAI.00083-16 10.4049/jimmunol.178.11.7222 10.1016/j.cell.2016.08.072 10.1002/path.1628 10.1111/j.1462-5822.2005.00612.x 10.1016/j.ajpath.2012.05.009 10.1128/JVI.02471-15 10.1038/nm.3109 10.1016/j.it.2014.08.007 10.1172/JCI97508 10.1016/j.smim.2014.09.006 10.1016/j.cmi.2019.02.015 10.1165/rcmb.2015-0146OC 10.1165/rcmb.2015-0147LE 10.1016/j.immuni.2013.04.004 10.1016/j.immuni.2012.12.001 10.1016/j.chom.2018.08.001 10.3389/fimmu.2019.01435 10.1038/mi.2013.127 10.1007/s00441-010-1032-2 10.1242/dev.129122 10.3389/fimmu.2020.00486 10.1128/IAI.05707-11 10.1093/infdis/jix625 10.1371/journal.ppat.1004603 10.1016/j.smim.2014.09.009 10.3389/fimmu.2019.00417 10.1007/s00281-015-0534-0 10.1007/s00702-011-0681-y 10.3324/haematol.2010.025924 10.3389/fimmu.2014.00384 10.1128/JVI.00994-16 10.1111/febs.13966 10.1084/jem.20071367 10.1128/IAI.70.8.4501-4509.2002 10.1016/S1473-3099(13)70253-6 10.4049/jimmunol.1800235 10.1007/s00247-017-3867-0 10.1136/adc.83.4.342 10.1172/JCI83379 10.3389/fimmu.2017.01120 10.1007/s00408-012-9440-6 10.1086/651492 10.5588/ijtld.10.0483 10.1016/S1473-3099(10)70078-5 10.1086/644784 10.1164/rccm.200806-858OC 10.2217/fmb.15.9 10.1097/INF.0000000000000331 10.1097/COH.0000000000000241 10.1097/QAI.0b013e31829f6df2 10.1097/01.aids.0000202648.18526.bf 10.1183/09031936.00091010 10.1038/ncomms9451 10.1002/ppul.23221 10.1097/INF.0000000000001784 10.3389/fped.2019.00159
Pediatric Research; Xu H, Blair RV et. al.
Mar 18th, 2021 - Tuberculosis (TB) is an increasing global emergency in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patients, in which host immunity is dysregulated and compromised. However, the pathogenesis and efficacy of therapeu...
https://emedicine.medscape.com/article/965086-overview
Mar 4th, 2020 - Practice Essentials Since the first cases of human immunodeficiency virus (HIV) infection were identified, the number of children infected with HIV has risen dramatically in developing countries, the result of an increased number of HIV-infected w...
https://doi.org/10.1111/pai.13155
Pediatric Allergy and Immunology : Official Publication O... Parigi S, Licari A et. al.
Feb 5th, 2020 - Nowadays, it is spreading the false perception that pediatric HIV infection has been almost completely disappeared in Italy, as well as in other Western countries, and it does not deserve the attention of the primary care pediatrician anymore. Her...
https://emedicine.medscape.com/article/2058830-print
Dec 4th, 2019 - The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, developed by the HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, were updated in September 2019.[1] Significant changes to guideli...
https://emedicine.medscape.com/article/2058830-overview
Dec 4th, 2019 - CDC Guidelines The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, developed by the HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, were updated in September 2019. [1] Significant ch...
News 2 results
https://www.mdedge.com/familymedicine/article/165686/hiv/fda-seeks-comments-pediatric-hiv-product-development
Infectious Disease Practitioner; Mark S. Lesney
May 14th, 2018 - The U. S.
http://www.fda.gov/regulatory-information/search-fda-guidance-documents/pediatric-hiv-infection-drug-development-treatment
Docket Number: FDA-2018-D-1638 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research The purpose of this guidance is to provide general recommendations on the development of antiret...
